Home » Archive by Category


San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Two New Clinical Studies Show Masimo Corporation Noninvasive Hemoglobin (SpHb) Demonstrated Similar Precision As Hemoglobin From Point Of Care Devices

October 16, 2014 – 5:00 am | Edit Post

IRVINE, CA–(Marketwired – October 16, 2014) – Masimo (NASDAQ: MASI) announced two new studies today that showed that noninvasive hemoglobin (SpHb®) demonstrated similar accuracy as hemoglobin measured by invasive hemoglobin analyzers when both SpHb and the invasive…

Ligand Pharmaceuticals Inc. To Host Analyst Day On November 18th In New York City

October 16, 2014 – 5:00 am | Edit Post

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host an Analyst Day on Tuesday, November 18, 2014 from 10:00 a.m. to 11:30 a.m. Eastern time (7:00 a.m. to 8:30 a.m. Pacific time) in New York City. The presentations will cover the following topics: Ligands business model and expanding portfolio of partnered and un-partnered assets Help employers find you…

Batu Biologics Awarded Exclusive License From University of California, San Diego (UCSD) for Drug That Stimulates Immune System To Kill Cancer

October 16, 2014 – 5:00 am | Edit Post

SAN DIEGO–(BUSINESS WIRE)–Batu Biologics, an immunotherapy company developing an anti-angiogenic cancer vaccine, announced today the signing of a license agreement with the Regents of the University of California, granting exclusive rights to novel peptide drugs developed at UC San Diego that have been proven to stimulate cancer-killing immune responses. Batu Biologics plans to utilize the licensed…

Paragon BioTeck To Exhibit At American Academy of Ophthalmology Annual Meeting In Chicago

October 16, 2014 – 5:00 am | Edit Post

PORTLAND, Ore., Oct. 15, 2014 /PRNewswire/ –Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, will be exhibiting at the American Academy of Ophthalmology (Booth #4550) in

Lombard Medical Technologies Announces First Aorfix Cases In New Zealand Following Expansion In Asia-Pacific Region

October 16, 2014 – 5:00 am | Edit Post

IRVINE, Calif. and LONDON, Oct. 16, 2014 (GLOBE NEWSWIRE) — Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced the successful completion of the first two EVAR cases performed in New Zealand…

CytRx Corporation Appoints As Chairman Of The Board

October 16, 2014 – 5:00 am | Edit Post

LOS ANGELES, Oct. 16, 2014 /PRNewswire/ –CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that its Board of Directors has appointed Steven A. Kriegsman, President, Chief Executive Officer and a Director…

Halt Medical, Inc. Announces Of IL, TX, OK, NM And MT Issue Positive Coverage Decisions For The Acessa Procedure For Women With Symptomatic Fibroids

October 16, 2014 – 5:00 am | Edit Post

LIVERMORE, Calif., Oct.16, 2014 /PRNewswire/ — Halt Medical, Inc. announced today that BlueCross & BlueShield of Illinois, Texas, Montana, New Mexico and Oklahoma, part of Health Care Service Corporation (HCSC), published updates to their Laparoscopic and Percutaneous Techniques for the Treatment of Uterine Fibroid Policies, and are now providing benefits for Halt Medical’s Acessa Procedure as a…

Alphatec Spine To Release Third Quarter 2014 Financial Results

October 16, 2014 – 5:00 am | Edit Post

CARLSBAD, Calif., Oct. 15, 2014 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global medical device company that provides spinal fusion technology solutions for patients with spinal disorders, will release its third quarter 2014 financial results…

Thermo Fisher Scientific Announces Its Ion PGM Dx Next Generation Sequencing System Is Now CE-Marked For In Vitro Diagnostic (IVD) Use

October 16, 2014 – 5:00 am | Edit Post

CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific today announced the successful CE-IVD registration of its new Ion PGM Dx System for sale in European countries. The Ion PGM Dx System was developed using the proven Ion Torrent next generation sequencing (NGS) technology, currently used to produce hundreds of thousands of tests in clinical research laboratories each year to uncover meaningful…

Illumina Admits First Startup Accelerator Class

October 15, 2014 – 12:47 pm | Edit Post

Bioinformatics giant Illumina (NASDAQ: ILMN) is getting into the accelerator game, along with other players in the life sciences and other fields. On Wednesday it announced the first three startups…

[[Click headline to continue reading.]]